apoB/apoA-I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy men

Atherosclerosis

Volumn 189, Issue 1, 2006, Pages 178-185

  Schmidt, C ^a   Fagerberg, B ^a   Wikstrand, J ^a   Hulthe, J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Apolipoproteins; Cardiovascular diseases; Carotid arteries; Femoral arteries; Ultrasonography

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMORAL ARTERY; FOLLOW UP; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SWEDEN;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ARTERIAL OCCLUSIVE DISEASES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; RISK FACTORS;

EID: 33646012202     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.031     Document Type: Article

References (35)

1. Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull 26 (2003) 1-9
2. Wallenfeldt K., Bokemark L., Wikstrand J., et al. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35 (2004) 2248-2252
3. Walldius G., and Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets of lipid-modifying therapy. J Int Med 255 (2004) 188-205
4. Walldius G., Jungner I., Holme I., et al. High lipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
5. Sniderman A.D., Furberg C.D., Keech A., et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 361 (2003) 777-780
6. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
7. Michelle F.C., and Frohlich J.J. Coronary artery disease in patients at low risk-apolipoprotein A-I as an independent risk factor. Atherosclerosis 155 (2001) 165-170
8. Quershi A.I., Giles W.H., Croft J.B., et al. Apolipoproteins A-1 and B and the likelihood of non-fatal stroke and myocardial infarction-data from the third national health and nutrition examination survey. Med Sci Monit 8 (2002) CR311-CR316
9. Hulthe J., Wikstrand J., Emanuelsson H., et al. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 28 (1997) 1189-1194
10. Held C., Hjelmdahl P., Eriksson S.V., et al. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina. Eur Heart J 22 (2001) 62-72
11. Schmidt C., Fagerberg B., and Hulthe J. Non-stenotic ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Atherosclerosis 181 (2005) 125-130
12. Bokemark L., Wikstrand J., Wedel H., et al. Insulin, insulin properties and intima-media thickness in the carotid artery in 58-year-old clinically healthy men. The atherosclerosis and insulin resistance study (AIR). Diabetic Med 19 (2002) 144-151
13. Wendelhag I., Wiklund O., and Wikstrand J. Intima-media thickness after cholesterol lowering in familial hypercholesterolemia. A three year ultrasound study of common carotid and femora arteries. Atherosclerosis 117 (1995) 225-236
14. Hulthe J., Wikstrand J., and Fagerberg B. Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the Atherosclerosis and Insulin Resistance (AIR) study. Clinical Science 100 (2001) 371-378
15. Schmidt C., Fagerberg B., and Hulthe J. 58-Year old men with non-stenotic carotid artery plaques and the relationship with cardiovascular risk factors and future cardiovascular events. Vascular Dis Prev 2 (2005) 129-134
16. Agewall S., Fagerberg B., Berglund G., et al. Multiple risk factor intervention in high-risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up. J Int Med 249 (2001) 305-314
17. World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part I: Diagnosis and Classification of Diabetes Mellitus. Geneva, Switzerland: World Health Organization; 1999.
18. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
19. Lakka H.-M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
20. Meisinger C, Loewel H, Mraz W, et al. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J; 2004 [electronic published ahead of print].
21. Talmud P.J., Hawe E., Miller G.J., et al. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease in middle-aged UK men. Arterioscler Thromb Vasc Biol 22 (2002) 1918-1923
22. Lamarche B., Moorjani S., Lupien P.J., et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five year follow-up of men in the Quebec cardiovascular study. Circulation 94 (1996) 273-278
23. Moss A.J., Goldstein R.E., Marder V.J., et al. Thrombogenic factors and recurrent coronary events. Circulation 99 (1999) 1522-2517
24. Hoff H.F., Heideman C.L., Noon G.P., et al. Localization of apo-lipoproteins in human carotid artery plaques. Stroke 6 (1975) 531-534
25. Fowkes F., Housley E., Cawood E., et al. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 384-392
26. Belcaro G., Fisher C., Veller M., et al. Screening asymptomatic subjects with subclinical atherosclerotic lesions with arterial ultrasonic biopsy The P.A.P. study. Vasa 22 (1993) 232-240
27. Kröger K., Kucharczik A., Hirche H., et al. Atherosclerotic lesions are more frequent in femoral arteries than in carotid arteries independent of increasing numbers of risk factors. Angiology 50 (1999) 649-654
28. Wendelhag I., Wiklund O., and Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 13 (1993) 1404-1411
29. Griffin B.A., Minihane A.M., Furlonger N., et al. Inter-relations between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clin. Sci. (Lond.) 97 (1999) 269-276
30. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease. An update. JACC 43 (2004) 1731-1737
31. Chiasson J.-L., Josse R.G., Gomis R., et al. Acarbose treatment and risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA 290 (2003) 486-494
32. Bush T.L., Miller S.R., Golden A.L., et al. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health 79 (1989) 1554-1556
33. Rosamond W.D., Sprafka J.M., McGovern P.G., et al. Validation of self-reported history of acute myocardial infarction: experience of the Minnesota Heart Survey Registry. Epidemiology 6 (1995) 67-69
34. Haapanen N., Miilunpalo S., Pasanen M., et al. Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 145 (1997) 762-769
35. Lampe F.C., Walker M., Lennon L.T., et al. Validity of a self-reported history of doctor-diagnosed angina. J Clin Epidemiol 52 (1999) 73-81